Latest 10-Q quarterly reports

Abony Acquisition Corp. I reports continued growth in its trust account due to interest income, while actively searching for a business combination target.

Aardvark Therapeutics reports significant clinical trial setbacks for ARD-101, including an FDA clinical hold and trial terminations, leading to increased operating expenses and net losses.

Sanara MedTech Inc. (SMTI) filed its Form 10-Q for the quarter ended June 30, 2026, reporting increased net revenue and Adjusted EBITDA, alongside the significant announcement of a merger agreement with MiMedx Group, Inc.

Rithm Acquisition Corp. reports its financial results for the quarter ended June 30, 2026, highlighting interest income and ongoing efforts to secure a business combination.

Broadwind, Inc. announced a significant increase in revenue and gross profit for the second quarter of 2026, driven by strong performance in its Gearing and Industrial Solutions segments, despite a continued net loss.

Mount Logan Capital Inc. reported a significant decline in revenues and net income for the second quarter of 2026, with Asset Management revenues down 32% and net loss widening.

The Eastern Company's Q2 2026 Form 10-Q reveals a substantial bargain purchase gain from recent acquisitions, offsetting a decline in net sales and demonstrating improved operational cash flow.

Eloxx Pharmaceuticals, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing increased operating expenses, significant net losses, and a substantial accumulated deficit, while also highlighting a recent public offering and Nasdaq uplisting.

National CineMedia's Q2 2026 filing shows a 12.7% revenue increase to $58.4 million, but the company continues to report net losses.

Rice Acquisition Corporation 3 reports continued growth in its trust account income for the second quarter of 2026, while still in the process of identifying a business combination target.

Netlist Inc. announced a substantial increase in net sales and a return to net income for the quarter ended June 27, 2026, driven by strong demand and strategic agreements.

Intrusion Inc. filed its Q2 2026 10-Q, revealing a substantial decrease in revenue and a widening net loss, while also announcing the acquisition of VigilAigent.

Pono Capital Four, Inc. reported net income for the second quarter of 2026 driven by trust account investments, while acknowledging substantial doubt about its ability to continue as a going concern.

Neurogene Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing increased R&D expenses and net losses, while highlighting positive long-term clinical data for its lead candidate, NGN-401.

Evolv Technologies Holdings, Inc. announced a significant increase in revenue and improved Adjusted EBITDA for the second quarter of 2026, driven by strong demand for its AI-powered screening solutions.

Brookfield Oaktree Holdings, LLC's Q2 2026 results show a significant increase in net income attributable to Class A unitholders, driven by unrealized investment gains, despite a decline in interest and dividend income.

Strategic Storage Trust VI, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing revenues, operating expenses, and financial condition.

Maze Therapeutics Inc. announced its financial results for the second quarter of 2026, highlighting progress in its MZE829 and MZE782 clinical programs and a strong cash position.

Mobia Medical, Inc. (MOBI) announced a significant increase in revenue for the second quarter of 2026, driven by strong adoption of its Vivistim System, following its successful Initial Public Offering.

Siebert Financial Corp. reported a net loss for the second quarter of 2026, with revenues increasing to $31.2 million, driven by growth in its Financial Services segment, but offset by increased expenses and impairments.

Bicara Therapeutics Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing progress in its ficerafusp alfa clinical trials and significant increases in operating expenses.

Tron Inc. announced its Q2 2026 results, showcasing a significant surge in net income primarily due to substantial unrealized gains from its digital asset investments.

Jaws Mustang Acquisition Corporation reports net income for Q2 2026 driven by warrant revaluation, while extending its business combination deadline to December 4, 2026, amidst ongoing liquidity concerns.

Seer, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a decrease in total revenue and continued net losses, while also detailing cost-saving measures and ongoing product development.

Veradermics, Inc. announced positive topline data for its VDPHL01 drug in pattern hair loss trials and significant capital raises, while also detailing substantial operating expenses and future funding needs.

Rare Earths Americas, Inc. reported a substantial increase in operating expenses and net losses for the second quarter of 2026, alongside material weaknesses in internal controls, despite successful IPO proceeds.

Better Home & Finance Holding Company reported its second quarter 2026 financial results, showing an increase in total net revenues but a continued net loss, alongside significant increases in compensation and technology expenses.

The 21Shares XRP ETF experienced a substantial drop in Net Asset Value (NAV) and XRP's market price during the second quarter of 2026, alongside a reduction in its sponsor fee.

NeuroPace reported a 17% increase in revenue for Q2 2026, reaching $22.8 million, but continued to post net losses and saw a decrease in cash and cash equivalents.

The 21Shares Dogecoin ETF (TDOG) reported a decrease in Net Asset Value (NAV) per Share by 21.67% for the quarter ended June 30, 2026, despite an overall increase in total NAV due to share creations.